MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Watch List: Layoffs of 10% or More, Strategic Corporate Review, Delisting, Regulatory, Financial and/or Legal Issues
Ikena Oncology, Inc. (NASDAQ: IKNA)*
Organization & Developments: Ikena Oncology
Parents
Ikena Oncology, Inc. (NASDAQ: IKNA)*
Children
2023: Ikena Oncology Receives FDA Fast Track Designation for Novel AHR Antagonist IK-175 in Combination with Nivolumab to Treat Urothelial Carcinoma
2024: Ikena Oncology Lays off 35 Percent of Workforce to Focus on Clinical Development
The firm is developing treatment candidates for various Hippo-mutated and other cancers.
Jumps
Finance & Acquisitions: Ikena Oncology
Key People: Ikena Oncology